Domov › Rakovina prostaty › Virginia › Charlottesville
Klinické štúdie Rakovina prostaty v meste Charlottesville, VA
15 štúdií pre Rakovina prostaty hľadá účastníkov v zariadeniach v meste Charlottesville a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Prebieha náborFáza 3
- University of Virginia Health System ( Site 0054), Charlottesville
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Prebieha náborFáza 3
- University of Virginia Comprehensive Cancer Center, Charlottesville
- University of Virginia, Charlottesville
- UVA Health Cancer Care Pantops, Charlottesville
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Prebieha náborFáza 3
- University of Virginia Cancer Center, Charlottesville
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
Prebieha náborFáza 2
- University of Virginia Cancer Center, Charlottesville
The Vanguard Study: Testing a New Way to Screen for Cancer
Prebieha náborVítaní zdravých dobrovoľníkov
- Sentara Martha Jefferson Hospital, Charlottesville
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Prebieha náborFáza 3
- University of Virginia Cancer Center, Charlottesville
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Prebieha náborFáza 2
- University of Virginia Comprehensive Cancer Center, Charlottesville
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1/2
- University of Virginia, Charlottesville
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prebieha náborFáza 3
- University of Virginia Cancer Center, Charlottesville
HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)
Prebieha náborFáza 1/2
- University of Virginia, Charlottesville
A Feasibility Study of Biometric Measurements Via Wearable Smart Watch Technology for Evaluation of Vasomotor Symptoms in Patients Treated With Androgen Deprivation Therapy for Prostate Cancer (Prostate 007)
Prebieha nábor
- University of Virginia Health System, Charlottesville
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Prebieha náborObservačná štúdia
- University of Virginia, Charlottesville
Remotely Monitored Exercise Interventions in Patients With mCSPC Undergoing ADT (Prostate 006)
Prebieha nábor
- University of Virginia, Charlottesville
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Prebieha náborFáza 1
- University of Virginia Cancer Center, Charlottesville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Prebieha náborObservačná štúdia
- Massive Bio SYNERGY-AI site, Charlottesville
Štúdie Rakovina prostaty v iných mestách
- New York City, NY103 štúdií
- Houston, TX76 štúdií
- Los Angeles, CA61 štúdií
- Boston, MA59 štúdií
- St. Louis, MO46 štúdií
- Chicago, IL45 štúdií
- San Francisco, CA45 štúdií
- Philadelphia, PA44 štúdií
- Baltimore, MD43 štúdií
- Nashville, TN42 štúdií
- Seattle, WA42 štúdií
- Washington, DC38 štúdií
Iné štúdie v Charlottesville
- Nemalobunkový karcinóm pľúc21 štúdií
- Akútna myeloidná leukémia16 štúdií
- Metastatická rakovina13 štúdií
- Rakovina endometria13 štúdií
- Rakovina (všetky typy)13 štúdií
- Rakovina pľúc13 štúdií
- Srdcové zlyhanie11 štúdií
- Rakovina vaječníkov10 štúdií
- Kolorektálny karcinóm10 štúdií
- Diabetes mellitus 1. typu9 štúdií
- Rakovina prsníka9 štúdií
- Rakovina pankreasu9 štúdií
Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.